{"transactions":[{"id":2555640,"issuer":{"id":87957,"kind":"organization","name":"Cue Health Inc.","symbol":"HLTH"},"owners":[{"id":135125,"kind":"organization","name":"Section 32 Fund 2, LP","position":1,"cik":"0001725306","reported_name":"Section 32 Fund 2, LP","relationship":{"ten_percent_owner":true}},{"id":135126,"kind":"organization","name":"Section 32 GP 2, LLC","position":2,"cik":"0001725307","reported_name":"Section 32 GP 2, LLC","relationship":{"ten_percent_owner":true}},{"id":86808,"kind":"person","name":"Maris William J","position":3,"cik":"0001722210","reported_name":"Maris William J","relationship":{"ten_percent_owner":true}}],"security":"Series B Preferred Stock","published_at":"2021-09-30T20:44:30.000Z","date":"2021-09-28","kind":"exercise","acquired":false,"shares":3485535,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 28, 2021, the Series B Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 28, 2021, the Series B Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 28, 2021, the Series B Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 28, 2021, the Series B Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are held of record by Section 32 Fund 2, LP (\"Fund 2\"). Section 32 GP 2, LLC (the \"GP\"), the general partner of Fund 2, and William J. Maris, the managing member of the GP, may be deemed to share voting and dispositive power over the shares held by Fund 2. Such person and entity disclaim beneficial ownership of shares held by Fund 2 except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3485535},"source":{"system":"sec-edgar","filing":"0001140361-21-033115","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628945/000114036121033115/form4.xml","form_type":"4"}},{"id":2555639,"issuer":{"id":87957,"kind":"organization","name":"Cue Health Inc.","symbol":"HLTH"},"owners":[{"id":135125,"kind":"organization","name":"Section 32 Fund 2, LP","position":1,"cik":"0001725306","reported_name":"Section 32 Fund 2, LP","relationship":{"ten_percent_owner":true}},{"id":135126,"kind":"organization","name":"Section 32 GP 2, LLC","position":2,"cik":"0001725307","reported_name":"Section 32 GP 2, LLC","relationship":{"ten_percent_owner":true}},{"id":86808,"kind":"person","name":"Maris William J","position":3,"cik":"0001722210","reported_name":"Maris William J","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2021-09-30T20:44:30.000Z","date":"2021-09-28","kind":"exercise","acquired":true,"shares":3485535,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 28, 2021, the Series B Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are held of record by Section 32 Fund 2, LP (\"Fund 2\"). Section 32 GP 2, LLC (the \"GP\"), the general partner of Fund 2, and William J. Maris, the managing member of the GP, may be deemed to share voting and dispositive power over the shares held by Fund 2. Such person and entity disclaim beneficial ownership of shares held by Fund 2 except to the extent of any pecuniary interest therein."}],"balance_after":3485535,"source":{"system":"sec-edgar","filing":"0001140361-21-033115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628945/000114036121033115/form4.xml","form_type":"4"}},{"id":3457805,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":135125,"kind":"organization","name":"Section 32 Fund 2, LP","position":1,"cik":"0001725306","reported_name":"Section 32 Fund 2, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135126,"kind":"organization","name":"Section 32 GP 2, LLC","position":2,"cik":"0001725307","reported_name":"Section 32 GP 2, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86808,"kind":"person","name":"Maris William J","position":3,"cik":"0001722210","reported_name":"Maris William J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-07-22T20:30:46.000Z","date":"2019-07-22","kind":"exercise","acquired":false,"shares":3250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 22, 2019, the Series B Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 22, 2019, the Series B Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 22, 2019, the Series B Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are held of record by Section 32 Fund 2, LP (\"Fund 2\"). Section 32 GP 2, LLC (the \"GP\"), the general partner of Fund 2, and William J. Maris, the managing member of the GP, may be deemed to share voting and dispositive power over the shares held by Fund 2. Such person and entity disclaim beneficial ownership of shares held by Fund 2 except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":464285},"source":{"system":"sec-edgar","filing":"0001104659-19-041303","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000110465919041303/a4.xml","form_type":"4"}},{"id":3457804,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":135125,"kind":"organization","name":"Section 32 Fund 2, LP","position":1,"cik":"0001725306","reported_name":"Section 32 Fund 2, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135126,"kind":"organization","name":"Section 32 GP 2, LLC","position":2,"cik":"0001725307","reported_name":"Section 32 GP 2, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86808,"kind":"person","name":"Maris William J","position":3,"cik":"0001722210","reported_name":"Maris William J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-22T20:30:46.000Z","date":"2019-07-22","kind":"exercise","acquired":true,"shares":464285,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 22, 2019, the Series B Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are held of record by Section 32 Fund 2, LP (\"Fund 2\"). Section 32 GP 2, LLC (the \"GP\"), the general partner of Fund 2, and William J. Maris, the managing member of the GP, may be deemed to share voting and dispositive power over the shares held by Fund 2. Such person and entity disclaim beneficial ownership of shares held by Fund 2 except to the extent of any pecuniary interest therein."}],"balance_after":464285,"source":{"system":"sec-edgar","filing":"0001104659-19-041303","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000110465919041303/a4.xml","form_type":"4"}}]}